treatment options

Real-world experience with switching from intravenous immunoglobulin to subcutaneous efgartigimod PH20 in patients with chronic inflammatory demyelinating polyradiculoneuropathy: A case series

Study Overview The transition from intravenous immunoglobulin (IVIg) to subcutaneous efgartigimod PH20 in patients diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy

Real-world experience with switching from intravenous immunoglobulin to subcutaneous efgartigimod PH20 in patients with chronic inflammatory demyelinating polyradiculoneuropathy: A case series Read Post »

Scroll to Top